Britain's GSK Shifts Production Of Malaria Vaccine To Bharat Biotech

Britain’s pharmaceutical company GlaxoSmithKline on January 27 agreed to transfer the production of world’s first effective malaria vaccine to India’s Bharat Biotech. While GSK will shift the manufacturing of the protein part of the vaccine, it will supply the immunological agent/vaccine booster to the India-based manufacturer. Reportedly, Bharat Biotech may become the sole supplier of the malaria vaccine by 2029, while GSK will continue to supply the booster to various countries.